Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹31 Cr
Revenue (TTM)
₹151 Cr
Net Profit (TTM)
₹-8 Cr
ROE
-9.2 %
ROCE
3.2 %
P/E Ratio
--
P/B Ratio
0.4
Industry P/E
39.68
EV/EBITDA
18.3
Div. Yield
0 %
Debt to Equity
2
Book Value
₹16.7
EPS
₹-1.7
Face value
10
Shares outstanding
45,536,256
CFO
₹-11.14 Cr
EBITDA
₹51.38 Cr
Net Profit
₹9.87 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indrayani Biotech
| -39.0 | -18.1 | -49.5 | -61.1 | -51.8 | 0.4 | -0.7 |
|
BSE 500
| -7.6 | -7.0 | -6.9 | 7.4 | 14.4 | 11.8 | 13.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Indrayani Biotech
| -69.0 | -44.0 | -16.8 | 183.9 | 259.7 | 16.4 | -17.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE 500
| 6.4 | 14.4 | 24.8 | 3.3 | 30.1 | 16.8 | 7.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indrayani Biotech
|
6.9 | 31.4 | 150.6 | -7.3 | -1.0 | -10.7 | -- | 0.4 |
| 32,975.0 | 37,150.0 | 4,888.8 | 378.3 | 18.3 | 19.6 | 98.2 | 24.0 | |
| 55.1 | 61.0 | 59.7 | -7.7 | -5.9 | -64.5 | -- | 5.6 | |
| 80.6 | 178.2 | 431.4 | 15.4 | 3.5 | 6.1 | 11.6 | 0.7 | |
| 0.6 | 13.0 | 72.7 | 0.2 | -- | 0.9 | 60.4 | 0.6 | |
| 561.9 | 14,948.5 | 23,987.9 | 681.0 | 6.5 | 13.2 | 22 | 2.6 | |
| 17.2 | 6.8 | 8.0 | -0.2 | -1.3 | -- | -- | -5.3 | |
| 3,220.9 | 1,14,615.5 | 17,607.7 | 1,769.1 | 9.9 | 12.8 | 64.9 | 8.5 | |
| 1.1 | 2.6 | 2.5 | -485.4 | -- | 0 | -- | -- | |
| 139.9 | 138.8 | 77.5 | 8.2 | 12.8 | 7.6 | 16.9 | 1.2 |
No Review & Analysis are available.
Indrayani Biotech Limited manufactures electric motors, generators, transformers and electricity distribution, and control apparatus in India. The company was incorporated in 1992 and is based in Pune, India.
Incorporated
1992
Chairman
NM Ranganathan
Managing Director
Kasiraman Sayee Sundar
Headquarters
Chennai, Tamil Nadu
Website
Looking for more details about Indrayani Biotech Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Indrayani Biotech Ltd is ₹6.90 (BSE) as of 18-Mar-2026 IST. Indrayani Biotech Ltd has given a return of -51.78% in the last 3 years.
Since, TTM earnings of Indrayani Biotech Ltd is negative, P/E ratio is not available.
The P/B ratio of Indrayani Biotech Ltd is 0.41 times as on 18-Mar-2026, a 95 discount to its peers’ median range of 7.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.94
|
|
2024
|
35.18
|
3.55
|
|
2023
|
22.14
|
4.37
|
|
2022
|
23.51
|
4.32
|
|
2021
|
0.00
|
1.10
|
The 52-week high and low of Indrayani Biotech Ltd are Rs 20.40 and Rs 6.71 as of 19-Mar-2026.
Indrayani Biotech Ltd has a market capitalisation of ₹ 31 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Indrayani Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.13
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.